Summary – Ross has developed proprietary technology to mine microbiomes, already discovering 110,000+ novel small molecules with potential applications across pharmaceuticals, agriculture, and beyond.

Why investors should tune in:

– First-mover advantage in an untapped market
– Technology validated by Los Alamos National Lab
– Platform business model with multiple revenue streams
– Potential to generate 4X the human knowledge on microbial molecules annually

Ross brings exceptional credentials as a serial entrepreneur who’s built Inc. 500 companies and secured backing from DARPA, NIH, and major research institutions.

WATCH ON: LinkedIn

Summary – Join us for an inspiring episode of Mastering the Numbers as host Joe Mallo sits down with Ross Youngs, the visionary founder and CEO of Biosortia. In this in-depth conversation, Ross shares his journey of groundbreaking innovation, from his early days in plastics manufacturing to revolutionizing drug discovery. Learn how Biosortia is leveraging advanced technology and natural resources to access molecules that could transform medicine, agriculture, and cosmetics. Ross also dives into the challenges of scaling a startup, the importance of partnerships, and how perseverance led to game-changing advancements in their mission to serve the world’s most critical needs. Discover how Biosortia is breaking barriers by unlocking 100% of nature’s molecular secrets, a feat supported by top institutions like DARPA, ARPA-E, and Los Alamos National Lab. Ross discusses the potential of their technology to reduce pharmaceutical costs, foster global health innovation, and fuel competition in critical markets. This is a must-watch for entrepreneurs, scientists, and anyone curious about the future of biotechnology.

Summary – Discover the immense, untapped power of nature through groundbreaking Industrial Scale Microbiome Mining. While microbes have shaped the planet and all life, their interactions with humans extend far beyond infectious disease. The microbial world remains a vast, underexplored reservoir of molecules with extraordinary potential.

Summary – The new mining toolbox will start slow worldwide, but as the pipelines fill with new opportunities, microbial access facilitates adoption, and technology advances will accelerate. It is likely, in short order, 3-5 years, that new opportunities in therapeutics will impact rare and orphan diseases. Other life science areas will also benefit, including agrochemicals, sustainability, remediation, carbon capture, advanced energy, and cosmetics. Within ten years of execution and widespread adoption, most pipelines will be traced to the opportunity of untapped microbes of the earth.”- Ross Youngs

Summary – Explore groundbreaking biotechnology advancements with Ross, an inventor with 75 patents. Discover how his work is unlocking nature’s hidden molecules and revolutionizing the health and technology sectors.

Summary – Ross Youngs is the CEO & Founder of Biosortia Microbiomics, which provides small molecules and datasets from their deep access to unculturable microbes in microbiomes, a valuable, proven source for future therapeutics.

View on:

LinkedIn,  Facebook,  YouTube